Literature DB >> 4957610

Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis.

A S Youmans, G P Youmans.   

Abstract

Youmans, Anne S. (Northwestern University Medical School, Chicago, Ill.), and Guy P. Youmans. Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Myobacterium tuberculosis. J. Bacteriol. 91:2146-2154. 1966.-The ribosomal fraction of the attenuated strain, H37Ra, of Mycobacterium tuberculosis was treated with trypsin alone, ethylenediaminetetraacetic acid (EDTA) alone, EDTA and pancreatic ribonuclease, or with trypsin and ribonuclease. After each of these treatments, the ribosomal fractions were injected intraperitoneally into male CF-1 mice to test their capacity to produce an immune response to infection with virulent tubercle bacilli, strain H37Rv. Removal of protein with trypsin left the immunogenicity unchanged; EDTA alone reduced immunogenicity in the smaller vaccinating doses; EDTA plus ribonuclease reduced the immunogenicity by approximately 50% in the highest (1.0 mg) vaccinating dose; ribonuclease alone, after treatment with trypsin, reduced immunogenicity also approximately 50%. A crude mycobacterial ribonucleic acid (RNA) was prepared by extraction of the ribosomal fraction with alcohol. This RNA preparation was as effective in producing an immune response as the ribosomal fraction from which it was prepared, unless the RNA was partially or completely degraded during the preparation. The effect of ribonuclease on the immunogenicity of the RNA was similar to that obtained with the ribosomal fractions, except that ribonuclease completely destroyed the immunogenicity of a partially degraded RNA. RNA appears to be an essential part of an immunizing substance in attenuated tubercle bacilli, which produces a high degree of immunity in mice; 50 mug (dry weight) will protect approximately 80% of the mice, and as little as 0.5 mug will protect approximately 30% of the mice. Mycobacterial RNA not incorporated in Freund's incomplete adjuvant was nonimmunogenic. Yeast RNA incorporated in Freund's incomplete adjuvant was not immunogenic.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4957610      PMCID: PMC316186          DOI: 10.1128/jb.91.6.2146-2154.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  29 in total

1.  RIBOSOMAL RNA ON THE SURFACE OF RIBOSOMES.

Authors:  M SANTER
Journal:  Science       Date:  1963-09-13       Impact factor: 47.728

2.  Effect of mycosuppressin on the respiration and growth of Mycobacterium tuberculosis.

Authors:  A S YOUMANS; G P YOUMANS
Journal:  J Bacteriol       Date:  1962-10       Impact factor: 3.490

3.  The autodegradation of ribonucleoprotein in Escherichia coli.

Authors:  H E WADE
Journal:  Biochem J       Date:  1961-03       Impact factor: 3.857

4.  Blood nucleases and infectious viral nucleic acids.

Authors:  R M HERRIOTT; J H CONNOLLY; S GUPTA
Journal:  Nature       Date:  1961-03-11       Impact factor: 49.962

5.  Dissociation of macromolecular ribonucleoprotein of yeast.

Authors:  F C CHAO
Journal:  Arch Biochem Biophys       Date:  1957-08       Impact factor: 4.013

6.  Ribonuclease. I. A new assay method with P32 labeled yeast ribonucleic acid.

Authors:  J S ROTH; S W MILSTEIN
Journal:  J Biol Chem       Date:  1952-05       Impact factor: 5.157

7.  Nucleoside-specific antibodies elicited by synthetic antigens.

Authors:  M Sela; H Ungar-Waron
Journal:  Fed Proc       Date:  1965 Nov-Dec

8.  FURTHER STUDIES ON A LABILE IMMUNOGENIC PARTICULATE SUBSTANCE ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS.

Authors:  A S YOUMANS; G P YOUMANS
Journal:  J Bacteriol       Date:  1964-02       Impact factor: 3.490

9.  NATURE OF THE LABILE IMMUNOGENIC SUBSTANCE IN THE PARTICULATE FRACTION ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS.

Authors:  A S YOUMANS; G P YOUMANS
Journal:  J Bacteriol       Date:  1964-10       Impact factor: 3.490

10.  Infectivity of ribonucleic acid from poliovirus in human cell monolayers.

Authors:  H E ALEXANDER; G KOCH; I M MOUNTAIN; O VAN DAMME
Journal:  J Exp Med       Date:  1958-10-01       Impact factor: 14.307

View more
  42 in total

1.  T-cell-independent macrophage activation in mice induced with rRNA from Listeria monocytogenes and dimethyldioctadecylammonium bromide.

Authors:  J F van den Bosch; I Y Kanis; A C Antonissen; W A Buurman; C P van Boven
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

2.  Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.

Authors:  P Hoops; N E Prather; J Berry; J M Ravel
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

3.  Resolution and identification of ribosomes from mycobacteria.

Authors:  L Trnka; E Wiegeshaus; D W Smith
Journal:  J Bacteriol       Date:  1968-02       Impact factor: 3.490

4.  Cell-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.

Authors:  M R Venneman; L J Berry
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

5.  Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium.

Authors:  W Johnson
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

6.  Relationship between tuberculin hypersensitivity and cellular immunity to infection in mice vaccinated with viable attenuated Mycobacterial cells or with Mycobacterial ribonucleic acid preparations.

Authors:  R G Neiburger; G P Youmans; A S Youmans
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

7.  The immunogenic activity of ribosomal fractions derived from Brucella abortus.

Authors:  M J Corbel
Journal:  J Hyg (Lond)       Date:  1976-02

8.  Gonococcal ribosomes as skin test antigens. II. Precision Of the Method, Attempts To Identify The Ribosomal Antigen, and Correlation with The Macrophage Migration Inhibition test.

Authors:  R C Judd; W L Koostra
Journal:  Br J Vener Dis       Date:  1976-02

9.  Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.

Authors:  W O Schalla; W Johnson
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

10.  Ribonuclease-sensitive ribosomal vaccines.

Authors:  R Gonggrijp; A C Antonissen; J F van den Bosch; C P van Boven
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.